1-20 of 448 results for subject:Testing
Librarians' tools
- Search time
- 0.329 seconds
- Solr query time
- 0.007 seconds
- Search query
- subject:Testing
- We searched for
- subject_t:Testing OR subject_ses:93252
Type
House
Session
Month
Department
More
Member
More
Primary member
More
Answering member
More
Legislative stage
Legislation
More
Subject
More
Publisher
To ask the Secretary of State for Defence, how long the Reliability and Growth trials for the Ajax armoured vehicle will last.
To ask the Secretary of State for Defence, how long the Reliability and Growth trials for the Ajax armoured vehicle will last.
The Reliability Growth Trials and subsequent analysis are expected to last 18 to 24 months.
To ask the Secretary of State for Defence, what milestones other than Reliability and Growth trials the Ajax armoured vehicle need to meet before it reaches initial operating capability.
To ask the Secretary of State for Defence, what milestones other than Reliability and Growth trials the Ajax armoured vehicle need to meet before it reaches initial operating capability.
Work to recover the Armoured Cavalry Programme is well underway and will be taken forward for formal approval by Ministers from this Department and His Majesty’s Treasury early in the New Year. Once that has concluded the Department will be in a position to report a revised delivery plan.
To ask the Secretary of State for Health and Social Care, if he will take steps to (a) develop test infrastructure and (b) recruit testing staff to test patients for Alzheimer's disease to allow early diagnosis and treatment with Lecanemab.
To ask the Secretary of State for Health and Social Care, if he will take steps to (a) develop test infrastructure and (b) recruit testing staff to test patients for Alzheimer's disease to allow early diagnosis and treatment with Lecanemab.
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources.
NICE has been asked by the Department to conduct an appraisal of lecanemab for treating early Alzheimer’s disease. The appraisal is anticipated to begin in late August 2023.
It is a pleasure to serve under your chairmanship, Mr Sharma. I thank the hon. Member for Strangford (Jim Shannon) for the nice things he said about me and congratulate him on securing this important debate. He is right: people would have been present if it had been possible, but...
It is a pleasure to serve under your chairmanship, Mr Sharma. I thank the hon. Member for Strangford (Jim Shannon) for the nice things he said about me and congratulate him on securing this important debate. He is right: people would have been present if it had been possible, but...
It is a pleasure to serve under your chairmanship, Mr Sharma, and to respond on behalf of the shadow Health and Social Care team. I pay tribute to the hon. Member for Strangford (Jim Shannon) for securing this important debate and for his continued advocacy on this issue. I particularly...
It is a pleasure to serve under your chairmanship, Mr Sharma, and to respond on behalf of the shadow Health and Social Care team. I pay tribute to the hon. Member for Strangford (Jim Shannon) for securing this important debate and for his continued advocacy on this issue. I particularly...
It is a pleasure to serve under your chairmanship, Mr Sharma. I thank the hon. Member for Strangford (Jim Shannon) for bringing forward this important debate. He has been a strong advocate for eye health for a long time. He speaks from huge knowledge and personal experience, and I listened...
It is a pleasure to serve under your chairmanship, Mr Sharma. I thank the hon. Member for Strangford (Jim Shannon) for bringing forward this important debate. He has been a strong advocate for eye health for a long time. He speaks from huge knowledge and personal experience, and I listened...
Absolutely. As the hon. Gentleman says, we are keen to constantly drive that rate up, and we can talk more offline about the different things that we can potentially do to drive it up even further. The healthy child programme recommends eye examinations at birth, six weeks and age two,...
Absolutely. As the hon. Gentleman says, we are keen to constantly drive that rate up, and we can talk more offline about the different things that we can potentially do to drive it up even further. The healthy child programme recommends eye examinations at birth, six weeks and age two,...
Will the Minister give way?
Will the Minister give way?
I give way with pleasure to the hon. Lady, who has been hot-footing it from a funeral to attend the debate. I will seamlessly fill in, so she can catch her breath. I congratulate her on making it here.
I give way with pleasure to the hon. Lady, who has been hot-footing it from a funeral to attend the debate. I will seamlessly fill in, so she can catch her breath. I congratulate her on making it here.
I honestly thank the Minister for giving way. I have just got here from the funeral of a dear friend, Roger Lewis, who, as a totally blind man, was also a strong advocate for a national plan for eye care in England and the devolved nations. I congratulate my dear...
I honestly thank the Minister for giving way. I have just got here from the funeral of a dear friend, Roger Lewis, who, as a totally blind man, was also a strong advocate for a national plan for eye care in England and the devolved nations. I congratulate my dear...
I am grateful for the hon. Lady’s intervention, and I will be happy to meet her. It sounds like there is an important connection between where she has just been and this debate. I am extremely happy to meet her to talk about that.
I will continue setting out our strategy....
I am grateful for the hon. Lady’s intervention, and I will be happy to meet her. It sounds like there is an important connection between where she has just been and this debate. I am extremely happy to meet her to talk about that.
I will continue setting out our strategy....
I mentioned earlier that one of the main goals of the huge £8 billion plus £2 billion investment is in elective recovery because, as the hon. Gentleman said, the pandemic has had a huge impact. We have already cleared the number of people waiting for two years. The next milestone...
I mentioned earlier that one of the main goals of the huge £8 billion plus £2 billion investment is in elective recovery because, as the hon. Gentleman said, the pandemic has had a huge impact. We have already cleared the number of people waiting for two years. The next milestone...
Motion that this House has considered a blueprint for eye health in England and the devolved nations. Agreed to on question. Sitting adjourned without question put.
Motion that this House has considered a blueprint for eye health in England and the devolved nations. Agreed to on question. Sitting adjourned without question put.
I beg to move,
That this House has considered a blueprint for eye health in England and the devolved nations.
I thank the Backbench Business Committee for scheduling this debate. The hon. Member for Battersea (Marsha De Cordova) was going to be here, but she has a funeral to attend. As she...
I beg to move,
That this House has considered a blueprint for eye health in England and the devolved nations.
I thank the Backbench Business Committee for scheduling this debate. The hon. Member for Battersea (Marsha De Cordova) was going to be here, but she has a funeral to attend. As she...
I thank the Minister for his helpful response. The target of providing retinopathy screening to 80% of those living with diabetes has been achieved. Are there any plans to try to reach the other 20%? I am diabetic. I had my retinopathy test about four weeks ago; I get it...
I thank the Minister for his helpful response. The target of providing retinopathy screening to 80% of those living with diabetes has been achieved. Are there any plans to try to reach the other 20%? I am diabetic. I had my retinopathy test about four weeks ago; I get it...
The answers are very helpful. One thing that all three Members referred to was the waiting list, and those who lose their eyesight just because they have been on a waiting list for diagnosis, examination and investigation. I know the pandemic created lots of problems in relation to the waiting...
The answers are very helpful. One thing that all three Members referred to was the waiting list, and those who lose their eyesight just because they have been on a waiting list for diagnosis, examination and investigation. I know the pandemic created lots of problems in relation to the waiting...
I thank the hon. Members who spoke in the debate. The hon. Member for Motherwell and Wishaw (Marion Fellows) brought a breadth of knowledge to it, and we thank her for that. As I said earlier, I always like to hear what the other devolved nations are doing, and she...
I thank the hon. Members who spoke in the debate. The hon. Member for Motherwell and Wishaw (Marion Fellows) brought a breadth of knowledge to it, and we thank her for that. As I said earlier, I always like to hear what the other devolved nations are doing, and she...
To ask the Secretary of State for Defence, with reference to his comments to the House of Commons Defence Select Committee on 2 November 2022, whether he expects Ajax to begin its reliability and growth trials in December 2022 or January 2023.
To ask the Secretary of State for Defence, with reference to his comments to the House of Commons Defence Select Committee on 2 November 2022, whether he expects Ajax to begin its reliability and growth trials in December 2022 or January 2023.
Analysis of the data and crew feedback from the user validation trials has concluded. The trials successfully met their objectives to establish the effectiveness of the modifications proposed by General Dynamics to address the noise and vibration concerns on Ajax. The trials ensured vehicle crews remained safely within noise and vibration levels, allowing progression to the Reliability Growth Trials that we intend to commence in January 2023.
To ask the Secretary of State for Defence, whether his Department has analysed the data from the user validation trials for the Ajax programme; and whether the vehicles have passed their user validation trials.
To ask the Secretary of State for Defence, whether his Department has analysed the data from the user validation trials for the Ajax programme; and whether the vehicles have passed their user validation trials.
Analysis of the data and crew feedback from the user validation trials has concluded. The trials successfully met their objectives to establish the effectiveness of the modifications proposed by General Dynamics to address the noise and vibration concerns on Ajax. The trials ensured vehicle crews remained safely within noise and vibration levels, allowing progression to the Reliability Growth Trials that we intend to commence in January 2023.
Ten minute rule motion for leave to bring in a Bill. Agreed to on question. Presentation and first reading (Bill 202). To be read a second time on 3 March 2023.
Ten minute rule motion for leave to bring in a Bill. Agreed to on question. Presentation and first reading (Bill 202). To be read a second time on 3 March 2023.